InMode (INMD) vs SI-BONE (SIBN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SI-BONE (SIBN) has outperformed InMode (INMD) over the past year, gaining 24.0% versus a loss of 6.4%. Over five years, SIBN leads with a -17.5% price change compared with -83.1% for INMD. SI-BONE is the larger company by market cap ($847.7 million vs $812.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | INMD | SIBN |
|---|---|---|
| Share price | $14.12 | $18.92 |
| Market cap | $812.24M | $847.74M |
| 1-day change | +0.25% | +0.29% |
| YTD return | -4.15% | -4.36% |
| 1-year return | -6.45% | +24.00% |
| 5-year return | -83.11% | -17.46% |
| P/E ratio (TTM) | 11.67 | — |
| Forward P/E | 10.29 | — |
| EPS (TTM) | $1.21 | $-0.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.67 | $21.89 |
| 52-week low | $12.72 | $11.48 |
| Distance from 52-week high | -15.33% | -13.59% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +14.56% | +33.33% |
| Average volume | 501.37K | 543.48K |
| Shares outstanding | 57.54M | 44.82M |
| Employees | 660 | 376 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SIBN has outperformed INMD by 30.4 percentage points over the past year.
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
About SI-BONE
SIBN stock →SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products.
Health Care · Medical/Dental Instruments · 376 employees
INMD vs SIBN FAQ
Which is bigger, InMode or SI-BONE?
SI-BONE (SIBN) is larger, with a market capitalization of $847.74M compared with $812.24M for InMode (INMD).
Which stock has performed better over the past year, INMD or SIBN?
SIBN returned +24.00% over the past 12 months, compared with -6.45% for INMD (price return, excluding dividends). Past performance does not predict future results.
Are InMode and SI-BONE in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for InMode and Medical/Dental Instruments for SI-BONE.